发明名称 Pharmaceutical composition.
摘要 <p>Topical ophthalmologically acceptable composition useful for reducing and controlling the elevated intraocular pressure associated with glaucoma which comprises an angiotensin converting enzyme (ACE) inhibitor in combination with an ophthalmologically acceptable carrier. Preferred compositions contain captopril or an ACE inhibitor of formula <CHEM> wherein A is <CHEM> R2 is alkyl, benzyl, benzylthio, benzyloxy, phenylthio or phenoxy; R1, R3, R4 and R6 are hydrogen or alkyl; R5 is hydrogen, alkyl or amino alkyl; p is o, 1 or 2; q is 0, 1 or 2, provided that the sum of p and q is 1 or 2 and that p is not 0 in formula Z; r is 1 or 2. a</p>
申请公布号 EP0114333(A2) 申请公布日期 1984.08.01
申请号 EP19830112757 申请日期 1983.12.19
申请人 SCHERING CORPORATION 发明人 WATKINS, ROBERT WAYNE
分类号 C07D207/16;A61K31/40;A61K31/403;A61K31/404;A61K31/405;A61K31/41;A61K31/47;A61K31/472;A61K38/55;A61P27/02;A61P27/06;C07D207/42;C07D209/42;C07D217/26;C07D495/10;C12Q1/37;(IPC1-7):61K37/02;61K31/40;07C103/52 主分类号 C07D207/16
代理机构 代理人
主权项
地址
您可能感兴趣的专利